Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.6116
+0.0094 (1.56%)
At close: Jul 21, 2026, 4:00 PM EDT
0.6036
-0.0080 (-1.31%)
After-hours: Jul 21, 2026, 5:47 PM EDT
Longeveron Employees
Longeveron had 38 employees as of December 31, 2025. The number of employees increased by 12 or 46.15% compared to the previous year.
Employees
38
Change (1Y)
12
Growth (1Y)
46.15%
Revenue / Employee
$32,000
Profits / Employee
-$590,237
Market Cap
19.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | 12 | 46.15% | 38 | 0 |
| Dec 31, 2024 | 26 | 2 | 8.33% | 26 | 0 |
| Dec 31, 2023 | 24 | 3 | 14.29% | 23 | 1 |
| Dec 31, 2022 | 21 | 1 | 5.00% | 19 | 2 |
| Dec 31, 2021 | 20 | 8 | 66.67% | 18 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| NextCure | 40 |
| Quince Therapeutics | 38 |
| Daré Bioscience | 24 |
| Quantum BioPharma | 17 |
| Lipocine | 14 |
| Werewolf Therapeutics | 14 |
| Cellectar Biosciences | 11 |
LGVN News
- 8 days ago - Longeveron presents positive laromestrocel data in Alzheimer’s disease - TheFly
- 8 days ago - Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer's Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer's Disease - GlobeNewsWire
- 15 days ago - Longeveron appoints Marie Washburn CFO - TheFly
- 15 days ago - Longeveron® Appoints Marie Washburn as Chief Financial Officer - GlobeNewsWire
- 20 days ago - Longeveron Transcript: AGM 2026 - Transcripts
- 4 weeks ago - New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer's Disease Accepted for Poster Presentation at the 2026 Alzheimer's Association International Conference (AAIC) - GlobeNewsWire
- 6 weeks ago - Longeveron granted SME status by European Medicines Agency - TheFly
- 6 weeks ago - Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA) - GlobeNewsWire